TABLE 3.
Subgroup analysis of synergistic gentamicin use overall
| Outcome | No. (%) of patients or daysa
|
P value | OR (95% CI)b | |
|---|---|---|---|---|
| With gentamicin (n = 63) | Without gentamicin (n = 44) | |||
| 30-Day mortality | 7 (11) | 2 (5) | 0.2 | 2.63 (0.5-13.3) |
| Hospital LOSc | 20 | 21 | 0.8 | |
| 30-Day microbiological cure | 57 (91) | 39 (89) | 0.8 | 1.22 (0.4-4.3) |
| Clearance of bacteremia | 7 | 9 | 0.9 | |
| Time to defervescence | 4 | 2 | 0.02 | |
a
Results represent the numbers of days (median values for clearance of bacteremia), except results for 30-day mortality and 30-day microbiological cure, which represent the numbers (percentages) of patients.
b
OR, odds ratio; 95% CI, 95% confidence interval.
c
LOS, length of stay.